Growth Hormone Releasing Hormone (GHRH) is one of the most studied hormonal peptides. Over the last 4 decades lots of analogs have been developed (sermorelin, tesamorelin, CJC-1295) to help scientists understand how the pituitary regulates GH via GHRH. One of the most commonly discussed is MOD GRF 1-29 (Tetrasubstituted GRF 1-29 or CJC-1295 without the […]
The post MOD GRF 1-29: What does the research say? appeared first on Medical News Bulletin.
When care goes wrong, it can leave more than a scar. A late scan, wrong medication, poor care, or missed signs may lead to many severe problems later. But not every poor care case is a legal claim. To show negligent medical care, a case must meet set legal conditions. If you think harm was […]
The post Four Things Patients Need to Know Before Making a Medical Negligence Claim in the UK appeared first on Medical News Bulletin.
Scientists have found the neural wiring that makes slow breathing work to calm you down, but there's a twist...
The post Ancient Neural Circuits Explain Why Yoga Breathing Calms You Down appeared first on Medical News Bulletin.
Once a year is the minimum for anyone with diabetes. People whose feet already show damage need checks every few months. A podiatrist is one of the health professionals who can do the exam, and nothing about it is painful. Years of high blood sugar can dull the nerves in your feet (peripheral neuropathy). When […]
The post How often should a podiatrist check your feet if you have diabetes? appeared first on Medical News Bulletin.
The North American Spine Society released a patient safety position statement addressing the education, training and competency required to perform spine interventions, according to a press release.
“NASS created the patient safety position statement for the benefit of spine surgeons and patients. There are increasingly more procedures being offered to patients that sound like traditional, well-studied standard-of-care procedures that are not,” Christopher P. Kauffman, MD, DFNS, the incoming president of NASS and orthopedic spine surgeon at Kauffman Spine Surgery, told Healio. “Our members
The FDA granted clearance to a rapid blood test designed to distinguish between bacterial and viral infections in as little as 15 minutes, according to the test’s manufacturer.
The test — known as Access MeMed BV (MeMed) — has been cleared for use in the United States in adults and children aged as young as 90 days.
MeMed has partnered with Beckman Coulter Diagnostics, which will distribute and run the test on its equipment at medical facilities throughout the United States
A press release announcing the FDA clearance said the test will “help clinicians reduce unnecessary antibiotic use,” which
AMA wants the FDA to hold botanical products derived from substances such as cannabis and kratom to the same scientific standards they maintain for approving other conventional drugs.
In a letter to the FDA, John J. Whyte, MD, MPH, AMA CEO and executive vice president, noted AMA is “deeply concerned” about the widespread use of these “natural” products without research-based evidence, and “strongly recommends” the FDA regulate them and determine their efficacy through research and clinical trials.
“As botanical manufacturers develop increasingly potent products in everything from gummies and
Differences in retinal blood vessel characteristics between the right and left eye could be linked to the severity of diabetic retinopathy, according to data published in Acta Ophthalmologica.
“The microvascular structures of the retina offer a noninvasive window for visualizing systemic vascular damage, potentially positioning the assessment of the severity of DR and systemic vascular disease in diabetic patients,” Stela Vujosevic, MD, PhD, FARVO, FEBO, head of the medical retina unit at IRCCS MultiMedica in Italy, and colleagues wrote, adding, “Recently, studies have
NEW ORLEANS — Haag-Streit and Marco Lombart announced the U.S. launch of the Octopus 910 full-field projection perimeter at the American Academy of Ophthalmology meeting.
This new Octopus, for glaucoma management, will provide clinicians with Cluster Analysis, Stimulus V testing, Polar Analysis assessment and structure-function comparison, according to a press release from Haag-Streit USA and Marco Lombart, an Advancing Eyecare company.
Josua Garius, global product manager, perimetry, at Haag-Streit, told Healio that Humphrey visual field data can be imported into the device for mixed
Coronary CT-planned and -guided percutaneous coronary intervention was noninferior to intravascular ultrasound-guided PCI for 12-month target vessel failure, a speaker reported.
The finding was among patients with chronic coronary syndrome or stabilized non-ST elevation acute coronary syndrome.
The results of the investigator-initiated, international, open-label, randomized, noninferiority P4 trial of coronary CT-guided vs. IVUS-guided PCI for patients with an indication for revascularization were presented at TCT 2026 and simultaneously published in The New England Journal of Medicine.
“Coronary